Latest Articles

Publication Date
Transcriptional coregulator ZMIZ1 modulates estrogen responses that are essential for healthy endometrial function.

Estrogen is a critical regulator of endometrial health. Aberrant estrogen stimulation can result in infertility, endometrial cancer, and endometriosis. Here, we identified Zinc Finger MIZ-Type Containing 1 (Zmiz1) as a …

Published: Dec. 1, 2025, midnight
Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort.

Background: Endometriosis affects an estimated 10% of reproductive-aged women and is associated with increased ovarian cancer risk. While BRCA1/2 mutations are established risk factors for ovarian cancer, their association with …

Published: Dec. 1, 2025, midnight
Young Kilkenny woman with endometriosis was told three times she had ovarian cancer - Kilkenny People

Young Kilkenny woman with endometriosis was told three times she had ovarian cancer Kilkenny People

Published: Nov. 30, 2025, 9:03 a.m.
‘It has made me live life more’: Jessie J on cancer, comebacks and cracking China - The Guardian

‘It has made me live life more’: Jessie J on cancer, comebacks and cracking China The Guardian

Published: Nov. 29, 2025, 6 a.m.
Dissecting endometrial cancer complexity in response to standard and targeted therapies - Nature

Dissecting endometrial cancer complexity in response to standard and targeted therapies Nature

Published: Nov. 28, 2025, 5:08 p.m.
Quarter of all ovarian cancer cases linked to endometriosis: expert - NewsNation

Quarter of all ovarian cancer cases linked to endometriosis: expert NewsNation

Published: Nov. 27, 2025, 10:47 p.m.
Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells - News-Medical

Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells News-Medical

Published: Nov. 27, 2025, 10:29 a.m.
m6A-Related SNPs in endometriosis and ovarian cancer: implications for chemoresistance and therapeutic targeting.

Ovarian cancer (OC) is highly lethal, largely due to late diagnosis and chemoresistance. Endometriosis (EM) increases the risk of specific OC subtypes, but the molecular connection between the two diseases …

Published: Nov. 27, 2025, midnight
DESTINY-Endometrial01 Will Examine T-DXd Plus Rilvegostomig or Pembrolizumab in HER2+ pMMR Endometrial Cancer - OncLive

DESTINY-Endometrial01 Will Examine T-DXd Plus Rilvegostomig or Pembrolizumab in HER2+ pMMR Endometrial Cancer OncLive

Published: Nov. 26, 2025, 7:03 p.m.
NICE recommends treatment for primary advanced or recurrent endometrial cancer - Pf Media

NICE recommends treatment for primary advanced or recurrent endometrial cancer Pf Media

Published: Nov. 26, 2025, 4:10 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!